Nicorette Bucomist Sabor Fruta Menta (Nicotine)

Nicotine, the active ingredient in Nicorette Bucomist Sabor Fruta Menta, is a nicotine replacement therapy presented as a buccal lozenge for oromucosal use. It helps adult smokers who wish to quit by reducing withdrawal symptoms and cravings, and it conforms to EU market standards with a fruit‑mint flavor to improve acceptability.

GNH USA supplies Nicorette Bucomist Sabor Fruta Menta as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence.

- Smoking cessation: reduces withdrawal symptoms and cravings, supporting gradual reduction of tobacco use. - Tobacco dependence: assists adults in quitting smoking by providing controlled nicotine exposure. - Relapse prevention: helps maintain abstinence after quitting by mitigating occasional cravings.

Nicotine replacement therapy can cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: soreness or tingling in the oral cavity. - Nausea: mild upset stomach after lozenge use. - Dyspepsia: indigestion or heartburn. - Hiccups: brief episodes following administration. - Increased salivation: excess saliva production. - Throat irritation: scratchy feeling in the throat.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Chest pain: unexpected discomfort in the chest area. - Irregular heartbeat: palpitations or arrhythmia. - Severe mouth ulcer: persistent ulceration in the oral mucosa. - Anaphylaxis: rare, life‑threatening systemic reaction. - Elevated blood pressure: sudden rise in systolic or diastolic pressure.

When using Nicorette Bucomist, consider the following safety measures.

- Assess dependence level: evaluate nicotine addiction severity before initiating therapy. - Allergy check: avoid use if known hypersensitivity to nicotine or excipients. - Cardiovascular risk: do not use in recent myocardial infarction or unstable angina without medical advice. - Hypertension monitoring: use cautiously in patients with high blood pressure. - Duration limit: adhere to recommended treatment length and do not exceed prescribed lozenges. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine may interact with several medicines, altering their effects or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - CYP2A6 inhibitors: elevated nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Alcohol: combined use may enhance nicotine’s cardiovascular effects. - Caffeine: may increase nervous system stimulation and side effects. - Other nicotine replacement products: risk of nicotine overdose if combined.